SNCA

There are 546 papers on SNCA in aging research: 2 trials and 103 observational studies in people, 308 in animals, 31 in cells, 97 reviews. The newest story, Nov 19, 2026: “Positive protein test linked to faster movement decline”.

Gene

546 papers study it138 findings

HGNCMGINCBI GeneTaxon

12 new papers in 30 daysSee all 546 papers on SNCA

At a glance

A mouse study reports shortened lifespan with transgenic A53T human SNCA expression. Independent labs find senescence induction in mouse cells and impaired motor function in mice, but a cell study reports reduced senescence and a mouse study shows no clear motor effect. Some trials registered across uses ended over a year ago without posted results or citing papers.

138 findings in 80 papers from 2013 to 2026, 12 of them since May 2026

Independent labs found the same change in cells, mice and people. 59 independent labs in 21 countries; 13 trials, 3 with no results posted.

“death age, Braak neurofibrillary tangles (NFT) stage, TDP-43, and α-synuclein were associated with declining trajectories”
Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying NeuropathologiesJournal of Alzheimer's disease : JAD2021doi:10.3233/jad-210293

4 of its findings point the other way.

Cells, mice and humans: replicated by independent labs. Worms or flies: a single group.
  • 59 independent labs in 21 countries
  • 4 findings against
  • 13 trials, 3 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 5 of 129 findings with company ties
  • 12 of 13 trials sponsored by developers of drugs aimed at it
  • Human trial2
  • Humans103
  • Animals211
  • Model organisms97
  • Cells31
  • In silico4

Interventions

14

Lactobacillus acidophilus slam_laa02

downin mice1downin worms1

1 study
  1. Lactobacillus acidophilus slam_laa02 decreases SNCA in a rotenone-induced mouse model.

    “These changes were accompanied by a notable reduction in α-synuclein expression”

    Animalsin a rotenone-induced mouse model

    A neuroprotective effect of newly isolated probiotic bacterium Lactobacillus acidophilus SLAM_LAA02 in a rotenone-induced mouse model of Parkinson's disease

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  2. Lactobacillus acidophilus slam_laa02 decreases SNCA in transgenic worms.

    “reduced α-synuclein expression in transgenic worms”

    Model organismsin transgenic worms

    A neuroprotective effect of newly isolated probiotic bacterium Lactobacillus acidophilus SLAM_LAA02 in a rotenone-induced mouse model of Parkinson's disease

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Lactobacillus acidophilus slam_laa02

Aerobic exercise

downin mice1

1 study
  1. Aerobic exercise decreases SNCA in mice (MPTP-induced Parkinson’s disease).

    “aerobic exercise significantly improved motor performance, increased the number of TH-positive and Nissl-positive neurons, reduced α-syn expression”

    AnimalsMPTP-induced Parkinson’s diseasemoderate-intensity motorized treadmill exercisesubstantia nigra60 min/day, 5 days/week6 weeksmales

    Aerobic Exercise Ameliorates Parkinson’s Disease by Activating FGF1/ERK1/2 Signaling and Suppressing Endoplasmic Reticulum Stress

    Research SquarePreprint

More on Aerobic exercise

Mitochondrial transplantation

downin human cells1

1 study
  1. Mitochondrial transplantation decreases SNCA in senescent SH-SY5Y cells.

    “alpha-synuclein expression was reduced, whereas dopamine production and the activities of enzymes involved in dopamine synthesis were increased after mitochondrial transplantation”

    Cellsin senescent SH-SY5Y cells

    Mitochondrial transplantation reverses the senescence phenotype of SH-SY5Y cells

    Molecular therapy. Advances

More on Mitochondrial transplantation

Time-restricted feeding

downin rats1

1 study
  1. Time-restricted feeding decreases SNCA in AD rats.

    “only TRF led to a significant decrease in α-synuclein levels”

    Animalsin AD ratshippocampus

    Time-Restricted Feeding Preserves Synaptic Function and Modulates Reelin and α-Synuclein in an Acute Amyloid-β Rat Model: A Comparative Study With Alternate-Day Fasting

    Journal of nutrition and metabolism

More on Time-restricted feeding

Urolithin A

downin rats1

1 study
  1. Urolithin A decreases SNCA in rotenone-lesioned rats.

    “UA treatment also downregulated the SNCA gene expression and α-synuclein levels in rotenone-lesioned rats.”

    Animalsin rotenone-lesioned rats

    Urolithin A Reverses Intranigral Rotenone-Generated Parkinsonism by Modulating DNA Methyltransferase 1 and α-Synuclein Axis in Rats

    ACS chemical neuroscience

More on Urolithin A

CRISPR/cas genome editing

downin reviews1

1 study
  1. CRISPR/cas genome editing decreases SNCA in PD.

    “reduction of alpha-synuclein expression in PD”

    Reviewin PD

    CRISPR/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects

    Ageing research reviews

More on CRISPR/cas genome editing

Psilocybin

downin reviews1

1 study
  1. Psilocybin decreases SNCA in preclinical models of Parkinson's disease.

    “Psilocybin, on the other hand, may increase repair of damaged neurons through psychoplastogenic activation of serotonergic pathways, particularly 5-HT2A receptor activation, ultimately increasing the release of brain derived neurotropic factor (BDNF) and the reduction of α-synuclein accumulation.”

    Reviewin preclinical models of Parkinson's diseaseneurons

    Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy

    Progress in neuro-psychopharmacology & biological psychiatry

More on Psilocybin

Theanine

downin mice1

1 study
  1. Theanine decreases SNCA in SAMP8 mice.

    “significant suppressions in the expressions of synapsin 2, α-synuclein, β-synuclein, and protein tau were observed by theanine administration”

    Animalsin SAMP8 micehippocampus

    Effect of Dietary L-Theanine on Protein Expression in the Hippocampus of Senescence-Accelerated Mice (SAMP8)

    Journal of nutritional science and vitaminology

More on Theanine

Hesperetin

downin worms1−36%

1 study
  1. Hesperetin decreases SNCA in NL5901 (36.3%).

    “supplementation with 100 μM Hst inhibited the accumulation of 36.3% αSN in NL5901”

    Model organismsin NL5901100 μM

    Citrus Flavonoid Hesperetin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Reduces Their Cytotoxicity: In Vitro and In Vivo Studies

    Journal of agricultural and food chemistry

More on Hesperetin

Antibiotic cocktail

downin animals1

1 study
  1. Antibiotic cocktail decreases SNCA in transgenic rats.

    “reduced α-Syn expression was detected in the olfactory bulbs (forebrain) of the TG rats.”

    Animalsin transgenic ratsolfactory bulb

    Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease

    Molecular neurodegeneration

More on Antibiotic cocktail

All 14

Effects

82

Cellular senescence

upin mice2downin cells1downin human cells1upin mouse cells1

4 studies
  1. SNCA inhibits cellular senescence in human cells (shown by siRNA-mediated SNCA depletion).

    “siRNA‐mediated SNCA depletion induced a senescence‐like state with increased β‐galactosidase activity, CDKN2A/p16 and TP53/p53 induction, and decreased SIRT1, eNOS, and glypican‐1.”

    Cellsshown by siRNA-mediated SNCA depletionhuman brain microvascular endothelial cell

    Protein loss weakened barriers in human brain vessel cells

    Aging cell

  2. SNCA induces cellular senescence in mice (α-syn-A53T overexpression in the SNpc).

    “overexpression of α-syn-A53T for one week induced significant pro-inflammatory senescence-associated secretory phenotype (SASP), increased cell senescence-related proteins (β-gal, p16, p21, H2A.X and γ-H2A.X)”

    Animalsα-syn-A53T overexpression in the SNpcsubstantia nigra pars compacta1 week

    Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease

    Acta pharmacologica Sinica

  3. SNCA prevents cellular senescence in cells (shown by siRNA knockdown).

    “siRNA-mediated silencing of SNCA consistently resulted in senescent phenotypes, such as eNOS downregulation, increased β-gal activity, decreased Sirt1 expression, and increased p53 expression, in ECs.”

    Cellsshown by siRNA knockdown

    Novel pathophysiological roles of α-synuclein in age-related vascular endothelial dysfunction

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  4. SNCA increases cellular senescence in mice (α-synuclein transgenic mice at early, presymptomatic stage).

    “Neuropathological examination of α-synuclein transgenic mice showed increased levels of phospho-α-synuclein and DNA double-strand breaks, as well as markers of cellular senescence”

    Animalsα-synuclein transgenic mice at early, presymptomatic stagebrain

    Senescence and impaired DNA damage responses in alpha-synucleinopathy models

    Experimental & molecular medicine

  5. SNCA induces cellular senescence in mouse cells (α-synuclein overexpression).

    “overexpression of α-synuclein leads to impaired DNA repair and cellular senescence.”

    Cellsα-synuclein overexpression

    Senescence and impaired DNA damage responses in alpha-synucleinopathy models

    Experimental & molecular medicine

More on Cellular senescence

Motor function

downin mice2downin flies1no changein mice1

4 studies
  1. SNCA showed no clear effect on motor function in mice (mThy1-hSNCA transgenic mouse model).

    “Furthermore, we did not observe pathophysiological or Tyrosine Hydroxylase alterations in the striatum or substantia nigra, nor motor deficits in our model.”

    AnimalsmThy1-hSNCA transgenic mouse modelmales

    A novel mouse model reproducing frontal alterations related to the prodromal stage of dementia with LEWY bodies

    Neurobiology of disease

  2. SNCA impairs motor function in mice (conditional expression in DA neurons).

    “expression of either WT or WT-CL1 α-syn was associated with an age-dependent degeneration of DA neurons and movement dysfunction”

    Animalsconditional expression in DA neurons

    The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation

    Journal of neurochemistry

  3. SNCA impairs motor function in SAMP8 (P8) genetic background.

    “Behavioral assessments, conducted at both 10 and 16 months of age, unveil motor impairments exclusive to P8 α-SynTg mice, a phenomenon conspicuously absent in α-SynTg mice.”

    Animalsin SAMP8 (P8) genetic background

    Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging

    Scientific reports

  4. SNCA impairs motor function in flies.

    “intestinal α-syn alone recapitulated many phenotypic and pathological features of PD, including impaired life span, loss of dopaminergic neurons, and progressive motor defects”

    Model organismsgut

    Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila

    Translational neurodegeneration

Triacylglycerols

downin worms2

2 studies
  1. SNCA decreases triacylglycerols in worms (aging worms).

    “αSyn reduces the overall content of triacylglycerols (TAG) and disrupts the structure of lipid droplets (LD) and mitochondria.”

    Model organismsaging worms

    Alpha-synuclein impairs triglyceride metabolism and mitochondrial structure in aging nematodes

    EMBO reports

  2. SNCA decreases triacylglycerols in worms.

    “αSyn strongly reduces overall content of triacylglycerols (TAG) and disrupts the structure of lipid droplets (LD).”

    Model organisms

    Condensate-Driven Triglyceride Depletion Links α-Synuclein to Mitochondrial Dysfunction

    bioRxiv : the preprint server for biologyPreprint

More on Triacylglycerols

Cognitive function

downin humans2

2 studies
  1. SNCA is linked with worse cognitive function in clinically unimpaired individuals.

    “performed worse on tests of executive function and working memory, and reported more LBD-related non-motor symptoms.”

    Humansin clinically unimpaired individuals

    Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. SNCA is linked with worse cognitive function in humans (amygdala-directed alpha-synuclein propagation trajectory).

    “The amygdala-directed trajectory is strongly associated with Alzheimers co-pathology, APOE {varepsilon}4 genotype, and poorer cognitive outcomes.”

    Humansamygdala-directed alpha-synuclein propagation trajectoryn = 304

    Alpha-synuclein propagation trajectories in a population-based postmortem cohort

    medRxivPreprint

Parkinson's disease

no changein mice1upin reviews1

2 studies
  1. SNCA showed no clear effect on Parkinson's disease in mice (SncaY39E or SncaS129D KI).

    “However, neurodegeneration in the substantia nigra was not observed up to 24 months of age.”

    AnimalsSncaY39E or SncaS129D KIsubstantia nigra

    Alpha-Synuclein Phosphomimetic Y39E and S129D Knock-In Mice Show Cytosolic Alpha-Synuclein Localization without Developing Neurodegeneration or Motor Deficits

    eNeuro

  2. SNCA increases Parkinson's disease.

    “This oligomeric α-syn stimulates pro-inflammatory signals, which may worsen PD symptoms and propagate chronic inflammation.”

    Review

    Alpha synuclein and inflammaging

    Heliyon

More on Parkinson's disease

Dopamine

downin mice1downin rats1

2 studies
  1. SNCA decreases dopamine in rats (Full-length human α-synuclein overexpression compared with age-matched wild-type rats).

    “Aged Snca+/+ rats have mild loss of SNpc DA neurons and decreased basal DA levels in the SN.”

    AnimalsFull-length human α-synuclein overexpression compared with age-matched wild-type ratssubstantia nigra

    Morpho-Functional Changes of Nigral Dopamine Neurons in an α-Synuclein Model of Parkinson's Disease

    Movement disorders : official journal of the Movement Disorder Society

  2. SNCA decreases dopamine in mice.

    “However, they displayed increased energy expenditure, reduced striatal dopamine (DA) and prolonged hyperactivity to a novel environment indicating impaired habituation.”

    AnimalsASYN overexpression in dopaminergic neurons compounded with Nurr1 hemizygosity ('2-hit-DA')C-terminally truncated ASYN(120)striatum

    Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons

    Neuroscience

More on Dopamine

Dopaminergic neuron loss

upin flies1upin mice1

2 studies
  1. SNCA induces dopaminergic neuron loss in flies.

    “intestinal α-syn alone recapitulated many phenotypic and pathological features of PD, including impaired life span, loss of dopaminergic neurons, and progressive motor defects”

    Model organismsgut

    Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila

    Translational neurodegeneration

  2. SNCA increases dopaminergic neuron loss in mice (transgenic expression in N103 mice).

    “loss of dopaminergic neurons in the substantia nigra, and progressive striatal synaptic degeneration.”

    Animalstransgenic expression in N103 micehuman α-synuclein 1-103 fragmentsubstantia nigra

    Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson's Disease

    Frontiers in aging neuroscience

Lifespan

downin flies1downin mice1

2 studies
  1. SNCA shortens lifespan in flies.

    “intestinal α-syn alone recapitulated many phenotypic and pathological features of PD, including impaired life span, loss of dopaminergic neurons, and progressive motor defects”

    Model organismsgut

    Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila

    Translational neurodegeneration

  2. SNCA shortens lifespan in mice (transgenic expression of A53T human alpha-synuclein).

    “Accumulation of A53T alpha-synuclein causes adult mice to develop severe motor impairment resulting in early death at 8-12 months of age.”

    Animalstransgenic expression of A53T human alpha-synuclein

    Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function

    PloS one

Blood-brain barrier leakage

downin mice1

1 study
  1. SNCA decreases blood-brain barrier leakage in mice (shown by global SNCA knockout).

    “Global SNCA‐knockout mice exhibited multiregional BBB leakage, reduced occludin, ZO‐1, and claudin‐5, and p53 immunoreactivity confined to CD31‐positive microvessels.”

    Animalsshown by global SNCA knockoutbrain microvasculature

    Protein loss weakened barriers in human brain vessel cells

    Aging cell

Endothelial permeability

downin human cells1

1 study
  1. SNCA decreases endothelial permeability in human cells (shown by SNCA depletion).

    “SNCA‐deficient HBMECs showed impaired proliferation and migration, loss of occludin and ZO‐1, increased permeability, and elevated BACE1 expression and activity”

    Cellsshown by SNCA depletionhuman brain microvascular endothelial cell

    Protein loss weakened barriers in human brain vessel cells

    Aging cell

All 82

Upstream

3

CALPAIN

mediatesin reviews1

1 study
  1. CALPAIN mediates SNCA in Parkinson's disease.

    “mediates toxic α-synuclein (α-syn) aggregation and neuron death”

    Reviewin Parkinson's disease

    Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson's Disease and Aging

    Biomedicines

More on CALPAIN

TNF-alpha

upin cells1

1 study
  1. TNF-alpha increases SNCA in cultured neurons.

    “TNF-α is the major inflammatory factor that drives cell-to-cell propagation of α-synuclein”

    Cellsin cultured neurons

    TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis

    Experimental & molecular medicine

More on TNF-alpha

Cellular senescence

upin cells1

1 study
  1. Cellular senescence increases SNCA in neurons.

    “secretion of α-synuclein was increased in senescent neurons”

    Cellsin neurons

    TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis

    Experimental & molecular medicine

More on Cellular senescence

Associations

25

Lipid acyl-chain remodeling

mixedin human cells1

1 study
  1. SNCA is associated with lipid acyl-chain remodeling in human cells (alpha-synuclein expression).

    “This acyl-chain remodeling was partially conserved in human dopaminergic neurons expressing aSyn.”

    Cellsalpha-synuclein expressionLUHMES-derived dopaminergic neuron7 days after lentiviral transduction

    Alpha-synuclein pathology alters lipids in mice and human cells

    Research SquarePreprint

Fundamental frequency variability and vocal intensity regulation

mixedin T. guttata1

1 study
  1. SNCA is associated with fundamental frequency variability and vocal intensity regulation in T. guttata.

    “In a gene-driven PD state there were greater alterations in f o variability and intensity regulation”

    Animalsalpha-synuclein overexpression induced by viral injections; compared with control treatmentArea X

    Vocal biomarkers of aging and Parkinson’s disease in a songbird

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Fundamental frequency variability and vocal intensity regulation

Depressive symptoms

mixedin humans1

1 study
  1. SNCA is associated with depressive symptoms in older patients with cognitive impairment.

    “α-synuclein (α-syn) is significantly associated with elderly patients' mental status such as anxiety and depression”

    Humansin older patients with cognitive impairmentcerebrospinal fluidn = 250

    Relationship between cerebrospinal fluid neurobiomarkers and symptoms in older patients with cognitive impairment: an observational clinical study

    Scientific reports

More on Depressive symptoms

Working memory index

upin humans1

1 study
  1. SNCA is associated with working memory index in REM sleep behavior disorder (12.52 ± 2.55 vs. 10.10 ± 3.98, p = 0.05).

    “αSyn‐positive participants showed significantly higher working memory index scores (12.52 ± 2.55 vs. 10.10 ± 3.98, p = 0.05)”

    Humansin REM sleep behavior disordercerebrospinal fluidn = 35

    The Impact of Striatal Dopaminergic Deficits and Alpha‐Synucleinopathy on Cognitive Function in REM Sleep Behavior Disorder

    AAIC 2025 abstract

More on Working memory index

Cognitive function

upin humans1

1 study
  1. SNCA is associated with cognitive function in REM sleep behavior disorder (26.60 ± 3.01 vs. 24.20 ± 3.64, p = 0.05).

    “αSyn‐positive participants showed significantly higher working memory index scores (12.52 ± 2.55 vs. 10.10 ± 3.98, p = 0.05) and overall MoCA scores (26.60 ± 3.01 vs. 24.20 ± 3.64, p = 0.05)”

    Humansin REM sleep behavior disordercerebrospinal fluidn = 35

    The Impact of Striatal Dopaminergic Deficits and Alpha‐Synucleinopathy on Cognitive Function in REM Sleep Behavior Disorder

    AAIC 2025 abstract

Gut transcriptome

mixedin rats1

1 study
  1. SNCA is associated with gut transcriptome in rats.

    “This set was also partially reflected in the gut transcriptome of the same rat model, suggesting a systemic impact of SNCA overload”

    Animalsgut

    Brain region-specific and systemic transcriptomic alterations in a human alpha-synuclein overexpressing rat model

    Aging

More on Gut transcriptome

Myelination-associated genes

mixedin rats1

1 study
  1. SNCA is associated with myelination-associated genes in frontal cortex.

    “In frontal cortex, dysregulation of myelination-associated genes agreed with Parkinson patient data as shown before”

    Animalsin frontal cortexfrontal cortex

    Brain region-specific and systemic transcriptomic alterations in a human alpha-synuclein overexpressing rat model

    Aging

More on Myelination-associated genes

Transcriptome

mixedin rats1

1 study
  1. SNCA is associated with transcriptome in rats.

    “revealing that SNCA overexpression leads to age-dependent transcriptomic changes that largely occur region-specific”

    Animalsbrain

    Brain region-specific and systemic transcriptomic alterations in a human alpha-synuclein overexpressing rat model

    Aging

More on Transcriptome

RNA splicing

upin mice1

1 study
  1. SNCA is associated with RNA splicing in G2-3 alpha-synuclein TG mice.

    “a convergent enrichment of RNA splicing pathways, corroborated by alternative splicing analyses”

    Animalsin G2-3 alpha-synuclein TG micehippocampus and midbrain

    Isolation of Pure Disease Specific Aging Trajectories in Spatial Transcriptomics via the Delta–Delta Method

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on RNA splicing

Opposite regional dynamics in glutamatergic neurons

mixedin mice1

1 study
  1. SNCA is associated with opposite regional dynamics in glutamatergic neurons in G2-3 alpha-synuclein TG mice.

    “ΔΔ uncovered opposite regional dynamics in glutamatergic neurons”

    Animalsin G2-3 alpha-synuclein TG micehippocampus and midbrain

    Isolation of Pure Disease Specific Aging Trajectories in Spatial Transcriptomics via the Delta–Delta Method

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

All 25

Funding

1 grant since 2020

National Institute of Neurological Disorders and Stroke$3.8M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    One worm study reports that SNCA lowers triacylglycerols in aging worms but impairs motility in α-synuclein-expressing worms.

  2. Summary written from the findings.

Latest

Dec 2025: 28Jan 2026: 21Feb 2026: 12Mar 2026: 18Apr 2026: 13May 2026: 17Jun 2026: 19Jul 2026: 11Aug 2026: 7Sep 2026: 6Oct 2026: 4Nov 2026: 11167 papers in 12 months
medRxiv

Positive protein test linked to faster movement decline

Movement scores worsened by 0.611 points a year in test-positive participants versus 0.139 in test-negative participants followed for up to 12 years.Movement scores worsened by 0.611 points a year in test-positive participants versus 0.139 in test-negative participants followed for up to 12 years.

Preprint: cohort · 2,532 peopleBiomarkers
medRxiv

Wrist tracking model detected Parkinson’s in people

The model scored 0.93 on a measure of how well it distinguished 133 people with Parkinson’s from 26 healthy controls.The model scored 0.93 on a measure of how well it distinguished 133 people with Parkinson’s from 26 healthy controls.

Preprint: case-control studyParkinson's disease
Alzheimer's Research & Therapy

Lower smell scores preceded mild cognitive impairment

Among 922 older adults, those who developed mild cognitive impairment had lower smell-identification scores than those who remained stable up to 10 years earlier.Among 922 older adults, those who developed mild cognitive impairment had lower smell-identification scores than those who remained stable up to 10 years earlier.

Cohort · 633 peopleMild cognitive impairment
Cell Reports

Gene change reduced dementia-linked protein clumps in mice

Experiments in genetically engineered mice found that the Christchurch mutation reduced some protein clumps associated with Alzheimer’s disease and other dementias.Experiments in genetically engineered mice found that the Christchurch mutation reduced some protein clumps associated with Alzheimer’s disease and other dementias.

Mouse studyMechanisms
Aging Cell

Protein loss weakened barriers in human brain vessel cells

In lab experiments, reducing alpha-synuclein, a protein, made layers of human brain blood-vessel cells leakier; suppressing an enzyme returned leakage to normal.In lab experiments, reducing alpha-synuclein, a protein, made layers of human brain blood-vessel cells leakier; suppressing an enzyme returned leakage to normal.

Human cell studyMechanisms

See all 546 papers on SNCA